Peer-Reviewed Journal Details
Mandatory Fields
Kealy, B,Liew, A,McMahon, JM,Ritter, T,O'Doherty, A,Hoare, M,Greiser, U,Vaughan, EE,Maenz, M,O'Shea, C,Barry, F,O'Brien, T
2009
June
Tissue Engineering Part C-Methods
Comparison of Viral and Nonviral Vectors for Gene Transfer to Human Endothelial Progenitor Cells
Published
()
Optional Fields
ADENOASSOCIATED VIRUS VECTORS TRANSGENE EXPRESSION HEMOPHILIA-A STEM-CELLS HEMATOPOIETIC PROGENITOR HUMAN BLOOD THERAPY NEOVASCULARIZATION ELECTROPORATION TRANSPLANTATION
15
223
231
Background/Aims: The ability of endothelial progenitor cells (EPCs) to home to sites of neoangiogenesis makes them attractive candidates for use in the field of gene therapy. The efficacy of this approach depends on the efficiency of the vector used for transgene delivery.Methods/Results: In this study, we have compared the efficiency of adenovirus, five serotypes of AAV2, VSVG-pseudotyped lentivirus, and nonviral plasmid/liposome DNA vectors to deliver the green fluorescence protein reporter gene to human early EPCs to determine efficacy and vector-related cell toxicity. Adenovirus proved most effective with efficiencies of up to 80% with low levels of cell death. Lower levels of expression were seen with other vectors. Electroporation proved unsuitable at the parameters tested. We have also identified at least two distinct subpopulations that exist in the heterogeneous parent EPC culture, one of which is amenable to transduction with adenovirus and one that is not. In addition, adenoviral transduction did not disrupt the ability of the cells to incorporate into endothelial structures in vitro.Conclusion: We have found adenovirus to be the most efficient of the vector systems tested for gene delivery to EPCs, an effect that is mediated almost entirely by one of two identified subpopulations.
DOI 10.1089/ten.tec.2008.0323
Grant Details
Publication Themes